HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells

Kentaro Hayashi, H. Pu, Jing Tian, Ibolya E. Andras, Yong Woo Lee, Bernhard Hennig, Michal Toborek

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Among the different factors which can contribute to CNS alterations associated with HIV infection, Tat protein is considered to play a critical role. Evidence indicates that Tat can contribute to brain vascular pathology through induction of endothelial cell activation. In the present study, we hypothesized that Tat can affect expression of P-glycoprotein (P-gp) in brain microvascular endothelial cells (BMEC). P-gp is an ATP-dependent cellular efflux transporter which is involved in the removal of specific non-polar molecules, including drugs used for highly active antiretroviral therapy (HAART). Treatment of BMEC with Tat1-72 resulted in P-gp overexpression both at mRNA and protein levels. These alterations were confirmed in vivo in brain vessels of mice injected with Tat1-72 into the hippocampus. Furthermore, pre-treatment of BMEC with SN50, a specific NF-κB inhibitor, protected against Tat1-72-stimulated expression of mdr1a gene, i.e. the gene which encodes for P-gp in rodents. Tat1-72-mediated changes in P-gp expression were correlated with increased rhodamine 123 efflux, indicating the up-regulation of transporter functions of P-gp. These results suggest that Tat-induced overexpression of P-gp in brain microvessels may have significant implications for the development of resistance to HAART and may be a contributing factor for low efficacy of HAART in the CNS.

Original languageEnglish
Pages (from-to)1231-1241
Number of pages11
JournalJournal of Neurochemistry
Volume93
Issue number5
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Human Immunodeficiency Virus tat Gene Products
Endothelial cells
P-Glycoprotein
Brain
Endothelial Cells
Highly Active Antiretroviral Therapy
Genes
tat Gene Products
Rhodamine 123
Pathology
Microvessels
HIV Infections
Blood Vessels
Rodentia
Hippocampus
Up-Regulation
Adenosine Triphosphate
Chemical activation
Gene Expression
Messenger RNA

Keywords

  • Blood-brain barrier
  • Endothelial cell
  • Highly active antiretroviral therapy
  • HIV-Tat protein
  • Nuclear factor kappa B
  • P-glycoprotein

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells. / Hayashi, Kentaro; Pu, H.; Tian, Jing; Andras, Ibolya E.; Lee, Yong Woo; Hennig, Bernhard; Toborek, Michal.

In: Journal of Neurochemistry, Vol. 93, No. 5, 06.2005, p. 1231-1241.

Research output: Contribution to journalArticle

Hayashi, Kentaro ; Pu, H. ; Tian, Jing ; Andras, Ibolya E. ; Lee, Yong Woo ; Hennig, Bernhard ; Toborek, Michal. / HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells. In: Journal of Neurochemistry. 2005 ; Vol. 93, No. 5. pp. 1231-1241.
@article{cc5d229c57dd4e37ae35ca734e79b875,
title = "HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells",
abstract = "Among the different factors which can contribute to CNS alterations associated with HIV infection, Tat protein is considered to play a critical role. Evidence indicates that Tat can contribute to brain vascular pathology through induction of endothelial cell activation. In the present study, we hypothesized that Tat can affect expression of P-glycoprotein (P-gp) in brain microvascular endothelial cells (BMEC). P-gp is an ATP-dependent cellular efflux transporter which is involved in the removal of specific non-polar molecules, including drugs used for highly active antiretroviral therapy (HAART). Treatment of BMEC with Tat1-72 resulted in P-gp overexpression both at mRNA and protein levels. These alterations were confirmed in vivo in brain vessels of mice injected with Tat1-72 into the hippocampus. Furthermore, pre-treatment of BMEC with SN50, a specific NF-κB inhibitor, protected against Tat1-72-stimulated expression of mdr1a gene, i.e. the gene which encodes for P-gp in rodents. Tat1-72-mediated changes in P-gp expression were correlated with increased rhodamine 123 efflux, indicating the up-regulation of transporter functions of P-gp. These results suggest that Tat-induced overexpression of P-gp in brain microvessels may have significant implications for the development of resistance to HAART and may be a contributing factor for low efficacy of HAART in the CNS.",
keywords = "Blood-brain barrier, Endothelial cell, Highly active antiretroviral therapy, HIV-Tat protein, Nuclear factor kappa B, P-glycoprotein",
author = "Kentaro Hayashi and H. Pu and Jing Tian and Andras, {Ibolya E.} and Lee, {Yong Woo} and Bernhard Hennig and Michal Toborek",
year = "2005",
month = "6",
doi = "10.1111/j.1471-4159.2005.03114.x",
language = "English",
volume = "93",
pages = "1231--1241",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells

AU - Hayashi, Kentaro

AU - Pu, H.

AU - Tian, Jing

AU - Andras, Ibolya E.

AU - Lee, Yong Woo

AU - Hennig, Bernhard

AU - Toborek, Michal

PY - 2005/6

Y1 - 2005/6

N2 - Among the different factors which can contribute to CNS alterations associated with HIV infection, Tat protein is considered to play a critical role. Evidence indicates that Tat can contribute to brain vascular pathology through induction of endothelial cell activation. In the present study, we hypothesized that Tat can affect expression of P-glycoprotein (P-gp) in brain microvascular endothelial cells (BMEC). P-gp is an ATP-dependent cellular efflux transporter which is involved in the removal of specific non-polar molecules, including drugs used for highly active antiretroviral therapy (HAART). Treatment of BMEC with Tat1-72 resulted in P-gp overexpression both at mRNA and protein levels. These alterations were confirmed in vivo in brain vessels of mice injected with Tat1-72 into the hippocampus. Furthermore, pre-treatment of BMEC with SN50, a specific NF-κB inhibitor, protected against Tat1-72-stimulated expression of mdr1a gene, i.e. the gene which encodes for P-gp in rodents. Tat1-72-mediated changes in P-gp expression were correlated with increased rhodamine 123 efflux, indicating the up-regulation of transporter functions of P-gp. These results suggest that Tat-induced overexpression of P-gp in brain microvessels may have significant implications for the development of resistance to HAART and may be a contributing factor for low efficacy of HAART in the CNS.

AB - Among the different factors which can contribute to CNS alterations associated with HIV infection, Tat protein is considered to play a critical role. Evidence indicates that Tat can contribute to brain vascular pathology through induction of endothelial cell activation. In the present study, we hypothesized that Tat can affect expression of P-glycoprotein (P-gp) in brain microvascular endothelial cells (BMEC). P-gp is an ATP-dependent cellular efflux transporter which is involved in the removal of specific non-polar molecules, including drugs used for highly active antiretroviral therapy (HAART). Treatment of BMEC with Tat1-72 resulted in P-gp overexpression both at mRNA and protein levels. These alterations were confirmed in vivo in brain vessels of mice injected with Tat1-72 into the hippocampus. Furthermore, pre-treatment of BMEC with SN50, a specific NF-κB inhibitor, protected against Tat1-72-stimulated expression of mdr1a gene, i.e. the gene which encodes for P-gp in rodents. Tat1-72-mediated changes in P-gp expression were correlated with increased rhodamine 123 efflux, indicating the up-regulation of transporter functions of P-gp. These results suggest that Tat-induced overexpression of P-gp in brain microvessels may have significant implications for the development of resistance to HAART and may be a contributing factor for low efficacy of HAART in the CNS.

KW - Blood-brain barrier

KW - Endothelial cell

KW - Highly active antiretroviral therapy

KW - HIV-Tat protein

KW - Nuclear factor kappa B

KW - P-glycoprotein

UR - http://www.scopus.com/inward/record.url?scp=20144379266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144379266&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2005.03114.x

DO - 10.1111/j.1471-4159.2005.03114.x

M3 - Article

VL - 93

SP - 1231

EP - 1241

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -